What is the treatment for priapism?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Priapism

The treatment of ischemic priapism should follow a stepwise approach, beginning with intracavernosal phenylephrine injection with or without aspiration/irrigation, followed by surgical shunting procedures if medical management fails. 1

Diagnosis and Classification

Priapism is defined as a persistent penile erection lasting more than 4 hours without sexual stimulation. Proper management requires distinguishing between two main types:

  1. Ischemic (low-flow) priapism (95% of cases):

    • Characterized by painful, rigid erection
    • Blood gas values: PO₂ <30 mmHg, PCO₂ >60 mmHg, pH <7.25
    • Urological emergency requiring immediate intervention
  2. Non-ischemic (high-flow) priapism (5% of cases):

    • Usually painless
    • Normal blood gas values
    • Often associated with perineal trauma
    • Not a medical emergency

Treatment Algorithm for Ischemic Priapism

First-Line Treatment

  1. Aspiration with or without irrigation:

    • Insert 19-21 gauge butterfly needle into lateral aspect of proximal penis
    • Aspirate old, dark blood
    • May include irrigation with normal saline
    • Resolution rate: approximately 30% 2
  2. Intracavernosal injection of phenylephrine:

    • Preferred sympathomimetic due to lower cardiovascular side effects
    • Dosage: Dilute to 100-500 μg/mL with normal saline
    • Administer 1 mL injections every 3-5 minutes for up to 1 hour
    • Resolution rate: 43-81% 2, 1
    • Monitor vital signs during administration, especially in patients with cardiovascular disease

Second-Line Treatment (if first-line fails)

Surgical shunting procedures:

  1. Distal (cavernoglanular) shunts (first choice):

    • Winter procedure (needle-based)
    • Ebbehøj procedure (scalpel-based)
    • Al-Ghorab procedure (excision of tunica albuginea at tip)
    • Resolution rates: 66-74% 2
    • Lower erectile dysfunction rates (≤25%) compared to proximal shunts
  2. Proximal shunts (if distal shunts fail):

    • Quackels procedure (cavernospongious)
    • Grayhack procedure (cavernosaphenous)
    • Resolution rates: 76-77% 2
    • Higher erectile dysfunction rates (approximately 50%)

Treatment for Non-ischemic Priapism

  1. Initial management: Observation (not an emergency)
  2. If treatment requested: Selective arterial embolization
    • Prefer temporary materials (autologous clot, absorbable gels)
    • Avoid permanent materials (coils, chemicals) when possible
    • Resolution rate: 74% with temporary embolization 2
    • Erectile dysfunction rate: 5% with temporary vs. 39% with permanent embolization 2

Special Considerations

Priapism with Underlying Disorders (e.g., Sickle Cell Disease)

  • Treat the priapism first with standard urologic interventions
  • Provide concurrent systemic treatment for the underlying disease
  • Do not delay penile-directed therapy while waiting for systemic treatments
  • Systemic treatments alone have poor resolution rates (0-37%) 2, 1

Duration-Based Approach

  • <4 hours: Intracavernosal phenylephrine alone may be sufficient
  • 4-24 hours: Aspiration/irrigation with phenylephrine injection
  • 24-48 hours: Begin with aspiration/irrigation and phenylephrine, lower threshold for surgical shunting
  • >48 hours: Consider aggressive approaches including surgical shunting
  • >72 hours: Sympathomimetics less effective; surgical shunting often required 2

Common Pitfalls to Avoid

  1. Delaying treatment - Untreated ischemic priapism >36 hours has high likelihood of permanent erectile dysfunction
  2. Using epinephrine instead of phenylephrine - Higher risk of cardiovascular side effects
  3. Not monitoring vital signs during sympathomimetic administration
  4. Proceeding to surgical shunting before adequate trials of phenylephrine and aspiration/irrigation
  5. Treating non-ischemic priapism with aspiration and sympathomimetics (ineffective and potentially harmful)
  6. Relying solely on systemic treatments for priapism associated with hematologic disorders

Follow-up Care

  • Schedule follow-up to assess erectile function recovery
  • Counsel patients regarding potential need for future erectile dysfunction treatments
  • Consider evaluation for underlying causes (medications, hematologic disorders, malignancies)

Remember that prompt intervention is crucial for ischemic priapism to preserve erectile function, while non-ischemic priapism can often be managed conservatively.

References

Guideline

Ischemic Priapism Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.